Siemens Fonds Invest’s Bio-Rad Laboratories Class A BIO Stock Holding History

Siemens Fonds Invest’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-228	Closed	-$55.5K	–	561
2025 Q1	$55.5K	Buy	+228	New	+$68.6K	﹤0.01%	562
2022 Q1	–	Sell	-349	Closed	-$265K	–	415
2021 Q4	$265K	Buy	+349	New	+$261K	0.02%	376

Other funds holding BIO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FPA

First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return

Siemens Fonds Invest's BIO Position: Q2 2025 in Review

Siemens Fonds Invest sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 228 shares — an estimated $55.5K sold.

Siemens Fonds Invest first reported a position in BIO in Q4 2021 and held it in 2 quarters. The position peaked at $265K in Q4 2021. 384 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

Siemens Fonds Invest reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
Siemens Fonds Invest sold 228 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $55.5K.
Siemens Fonds Invest first reported a position in Bio-Rad Laboratories Class A in Q4 2021 and held it in 2 quarters.
Siemens Fonds Invest's Bio-Rad Laboratories Class A position peaked at $265K in Q4 2021.
384 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on Siemens Fonds Invest's 13F filing for Q2 2025, filed 14 Aug 2025.